Evidence map›Paper›PMID 21233176›Full record

ReviewJournal of nuclear medicine : official publication, Society of Nuclear Medicine2011

Molecular imaging of hypoxia.

Satish K Chitneni, Gregory M Palmer, Michael R Zalutsky, Mark W Dewhirst

Abstract readReview
In one paragraph

Review in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. In vitro and in vivo characterization of [European journal of nuclear medicine and molecular imaging · 2023
    Article
  5. Article
  6. Synthesis of a 2-nitroimidazole derivative N-(4-[EJNMMI radiopharmacy and chemistry · 2022
    Article
  7. Article
  8. Review
  9. Two-Photon Phosphorescence Lifetime Microscopy.Advances in experimental medicine and biology · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Tumor Microenvironment Targeted Nanotherapy.Frontiers in pharmacology · 2018
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Satish K ChitneniDepartment of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Gregory M Palmer
Michael R Zalutsky
Mark W Dewhirst

Funding

TISSUEP01CA042745 · NCI · DUKE UNIVERSITY · PI JONES, ELLEN L · 1987 to 2009
$28.6M
TUMOR SUPPRESSOR GENES IN HUMAN MEDULLOBLASTOMAP50NS020023 · NINDS · DUKE UNIVERSITY · PI BIGNER, DARELL D · 1985 to 2013
$17.3M
X-RAY RESEARCH AND DEVELOPMENT WITH/WITHOUT LIVE ANIMALSP41RR005959 · NCRR · DUKE UNIVERSITY · PI DZAU, VICTOR J · 1990 to 2011
$16.0M
RADIOTHERAPY USING MONOCLONAL ANTIBODIES AND ASTATINER01CA042324 · NCI · DUKE UNIVERSITY · PI ZALUTSKY, MICHAEL ROD · 1985 to 2020
$4.6M
Heat And Radiation Effects On Tumor MicrocirulationR01CA040355 · NCI · DUKE UNIVERSITY · PI DEWHIRST, MARK WESLEY · 1985 to 2013
$4.5M
ASTATINE AND IODINE RADIOLABELED MONOCLONAL ANTIBODIESR37CA042324 · NCI · DUKE UNIVERSITY · PI ZALUTSKY, MICHAEL ROD · 1999 to 2008
$3.8M
NCI NIH HHS CA40355NCI NIH HHS CA42324NCI NIH HHS P01 CA042745NCI NIH HHS R01 CA040355NCI NIH HHS R01 CA042324NCI NIH HHS R37 CA042324NCRR NIH HHS P41 RR005959NINDS NIH HHS P50 NS020023
6 · The paper itself

Abstract

A wide variety of imaging approaches have been developed in the past few decades for monitoring tumor oxygenation and hypoxia in vivo. In particular, nuclear medicine has seen the development of several radiolabeled hypoxia markers and is the preferred method for imaging of tumor hypoxia. Hypoxia imaging is increasingly being used in the clinical setting and is progressing from a mere detection method to application in individualization of chemoradiotherapy.

Indexed as

HumansHypoxiaMisonidazoleNeoplasmsNeovascularization, PathologicNitroimidazolesPositron-Emission TomographyRadiographyRadiopharmaceuticalsfluoroazomycin arabinosideMisonidazoleNitroimidazolesRadiopharmaceuticals

Identifiers

PMID21233176
PMCPMC3500596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.